These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3910774)

  • 41. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
    Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP; Leese GP; Peters JR; Owens DR
    J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of mild hypertension with captopril and captopril with hydrochlorothiazide. Impact on blood pressure values and quality of life].
    Escobar E; Roessler E; Zarate H; Román O; Valdés G; Medina E
    Rev Med Chil; 1993 Mar; 121(3):253-9. PubMed ID: 8248636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hemodynamic and respiratory effects of phentolamine in pulmonary hypertension secondary to chronic obstructive syndrome].
    Domenighetti G; Leuenberger P; Perret C
    Schweiz Med Wochenschr; 1985 Jan; 115(3):99-103. PubMed ID: 3975579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chronic obstructive lung diseases associated with systemic arterial hypertension].
    Kubyshkin VF; Soldatchenko SS; Konovalov VI
    Ter Arkh; 1985; 57(2):114-6. PubMed ID: 2860730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinico-functional evaluation of chronic obstructive lung diseases in association with hypertension].
    Soldatchenko SS; Kononenko IN; Rudieva NB; P'iankov AF
    Vrach Delo; 1991 Jun; (6):42-3. PubMed ID: 1891848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Aspecific bronchial reactivity during pharmacologic treatment of arterial hypertension].
    Bianco C; Cosmi F; Mollaioli M; Ricca M
    Minerva Med; 1987 Mar; 78(5):329-32. PubMed ID: 3822225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of captopril on blood pressure and respiratory function compared to verapamil in patients with hypertension and asthma.
    Riska H; Sovijärvi AR; Ahonen A; Salorinne Y; Sundberg S; Stenius-Aarniala B
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):57-61. PubMed ID: 1688983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of hypertension in the elderly with captopril.
    Birbari AE; Dauk M; Mukaddam-Daher S
    Angiology; 1987 May; 38(5):363-7. PubMed ID: 3296862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Captopril in the ambulatory treatment of arterial hypertension in diabetics].
    Jovanović D
    Med Arh; 1987; 41(5):257-64. PubMed ID: 3078017
    [No Abstract]   [Full Text] [Related]  

  • 51. Renal and pulmonary effects of angiotensin converting enzyme inhibition in chronic hypoxic lung disease.
    Oliver RM; Peacock AJ; Fleming JS; Waller DG
    Thorax; 1989 Jun; 44(6):513-5. PubMed ID: 2669225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy of captopril in the long-term treatment of essential hypertension of moderate-medium degree].
    Giuntoli F; Guidi G; Galeone F; Rossi A; Giacomelli A; Saba P
    Clin Ter; 1985 Nov; 115(4):261-5. PubMed ID: 3910331
    [No Abstract]   [Full Text] [Related]  

  • 53. [Captopril in the treatment of essential hypertension in old age].
    Nieto J; Alcázar JM; Ruilope LM; Rodicio JL
    Med Clin (Barc); 1988 Jan; 90(2):50-2. PubMed ID: 3279278
    [No Abstract]   [Full Text] [Related]  

  • 54. Geriatrics nephrology.
    Zawada ET
    J Clin Pharmacol; 1992 Apr; 32(4):310-6. PubMed ID: 1569233
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of essential arterial hypertension with captopril. Ambulatory study of drug surveillance, with special reference to the aged patient].
    Liberatore SM; Donà G; Botta G
    Clin Ter; 1985 Nov; 115(3):159-68. PubMed ID: 3910329
    [No Abstract]   [Full Text] [Related]  

  • 56. Pulmonary function and airway responsiveness during long-term therapy with captopril.
    Boulet LP; Milot J; Lampron N; Lacourcière Y
    JAMA; 1989 Jan; 261(3):413-6. PubMed ID: 2642559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Agranulocytosis induced by captopril after 4 months of treatment].
    Fernández Seara J; Domínguez Alvarez LM; Rodríguez Pérez R; Pereira Jorge JA; Rodríguez Canal A
    An Med Interna; 1991 Aug; 8(8):398-400. PubMed ID: 1768752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of treatment with captopril on the quality of life in hypertensive patients. Multicenter study in ambulatory patients].
    Liberatore S; Botta GF; Uccioli L
    Riv Eur Sci Med Farmacol; 1987 Dec; 9(4):437-51. PubMed ID: 3334184
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of captopril on hemodynamics and physical exertion tolerance in patients with arterial hypertension].
    Bakhshaliev AB; Ibragimov MA; Savenkov PM
    Kardiologiia; 1988 Apr; 28(4):58-61. PubMed ID: 3292812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postmarketing surveillance of captopril for hypertension.
    Chalmers D; Whitehead A; Lawson DH
    Br J Clin Pharmacol; 1992 Sep; 34(3):215-23. PubMed ID: 1389946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.